In vivo PAI of MSNPs biodistribution showed their specific accumulation into highly metastatic and chemoresistant human pancreatic cancers of orthotopic mouse models, due to the targeting of overexpressed UPAR, as confirmed by ex vivo analysis. This evidence concerns the gene PLAUR and pancreatic neoplasm.